Pramote Hochareon, M.D., Ph.D.

Medtech inventor & entrepreneur, biomedical engineer, scientist, NirvaMed Inc., Siriraj Medical School

[Davide Capodanno @DFCapodanno]

Three flights and 15 hours later, here we are at last! San Diego: where Marvel unveils the secrets of its multiverse and the @crfheart Avengers bring together one of the must-attend events of the year. See you around. #TCT2026

[Pramote Hochareon, M.D., Ph.D. @hochareon]

Honored to share my experience from NirvaMed and my thoughts on patents for med-drvice startups on at the CEO Club hosted by the Stock Exchange of Thailand.

[Pramote Hochareon, M.D., Ph.D. @hochareon]

Feel honored to share our progress. Will also share my experience from research to innovation as well.

[Pramote Hochareon, M.D., Ph.D. @hochareon]

Thanks to @supachaiMD for inviting me to share my thoughts and experience and to learn from many great minds around the world! Many new friendships were made too! 😇🤗🥰💡

[Pramote Hochareon, M.D., Ph.D. @hochareon]

@HSandhyavenu @DLBHATTMD @crfheart @TCTConference Hello Harigopal, I am the person who took this picture for you. I started NirvaMed--we are developing a rapid & localized heart cooling for STEMI. Dr. Bhatt is also our advisor. If you are interested, we would love to get your input for our development too. Thanks!

[Pramote Hochareon, M.D., Ph.D. @hochareon]

Team NirvaMed, our first TCT presentation by Dr. Cindy Clague, our Chief Research Scientist

[Gregg W. Stone MD @GreggWStone]

Our publ in JACC Int on DAPT d/c after PCI. Largest and most detailed study to date (ADAPT-DES, n=8582 all-comers). Unplanned premature d/c (~1/6 pts, #1 cause surgery/trauma) was strongly associated with cardiac death, MI and ST, esp if d/c w/i 90d, and esp if both ASA & P2Y12i.

[Pramote Hochareon, M.D., Ph.D. @hochareon]

@NathanMechEng Yes